πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 248 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9211323

Compositions and methods for administration of vaccines against dengue virus

Takeda Vaccines, Inc. Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9138432

Methods for the administration of iloperidone

VANDA PHARMACEUTICALS INC. Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066883

Administration of cells and cellular extracts for rejuvenation

REGENICS AS Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9050299

Administration of growth factors for the treatment of CNS disorders

The Regents of the University of California Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9050302

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9028887

Method improve spatial memory via pterostilbene administration

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018170

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012467

Compositions for intratumoral administration

Covidien LP Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012508

Administration of intravenous ibuprofen

Cumberland Pharmaceuticals Inc. Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012496

Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihy

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9005604

Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8952029

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8920373

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906901

Administration of dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8883206

Pharmaceutical composition and administrations thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809400

Method to ameliorate oxidative stress and improve working memory via pterostilbene adminis

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802107

VEGF antagonist formulations for intravitreal administration

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802628

Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administ

IRONWOOD PHARMACEUTICALS, INC. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772306

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

Jazz Pharmaceuticals, Inc. Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728526

Coacervate microparticles useful for the sustained release administration of therapeutic a

The United States of America, Represented by Secretary of Department of Health and Human Services, NIH Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653107

Fentanyl composition for nasal administration

Takeda Pharma A/S Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8652443

Foamable microemulsion compositions for topical administration

Precision Dermatology, Inc. Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8586610

Methods for the administration of iloperidone

VANDA PHARMACEUTICALS INC. Β· Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8552034

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropane

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted